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INTRODUCTION
Multiple myeloma (MM) is a human B-cell neoplasm char-
acterized by the clonal expansion of malignant plasma cells
in the bone marrow. The cause of this disease is only partial-
ly understood, but the production of soluble factors by the
myeloma cells is likely to be involved. The most important
complications are hypercalcemia associated with rapid skele-
tal dissolution, acute or chronic renal insufficiency, and infec-
tion. All these, along with less common complications such
as the hyperviscosity syndrome, hyperuricemia, and neuro-
logic involvement, must be recognized and managed appro-
priately to achieve optimal results from primary therapy. 
The serum hyperviscosity syndrome has been described
clinically as the triad of bleeding, visual signs and symptoms,
and neurologic manifestations (1, 2). This oncologic emer-
gency occurs in patients with IgM, IgG, and IgA monoclon-
al gammopathies as well as in some patients with polyclon-
al immunoglobulin disorders (3).
We reported a patient with hyperviscosity-induced cere-
bral infarction as the first sign of IgG multiple myeloma based
on clinical, laboratory, brain MRI, and bone marrow biopsy.
CASE REPORT
A 68-yr-old right-handed woman was admitted to Chon-
nam National University Hospital on 6 March, 2002 due
to hypesthesia and monoplegia in the left leg. She also com-
plained of headache and dizziness. Mild anemia had been dis-
covered three months before admission, but was not treated.
The patient had no risk factors of stroke except old age.
On admission, physical examination revealed an anemic
conjunctiva without icteric sclera. She had no lymphadenopa-
thy, and no palpable mass on her abdomen. Vital signs were
normal. Dilated fundoscopic examination revealed no abnor-
malities. There was no abnormality in EKG and echocardio-
graphy. Her mental status was alert. Other neurological exami-
nations were normal except monoplegia, hypesthesia, increased
deep tendon reflex (3+) with ankle jerks, and up-going Babin-
ski in the left leg. 
Diffusion- and T2-weighted MRI revealed a hyperintense
lesion in the callosomarginal territory of the right anterior
cerebral artery, and MR angiography did not show signifi-
cant stenosis on the intra- and extracranial artery (Fig. 1).
Laboratory data were as follows: hematocrit 26.6% (normal,
37-52), hemoglobin 8.2 g/dL (normal, 12-18), erythrocyte
sedimentation rate 127 mm/hr (normal, below 20), leukocyte
4.6×103/ L (normal, 4.3-10.8) and platelet counts 190×
103/ L (normal, 130-400). A peripheral blood smear showed
extensive rouleaux formation. The prothrombin time was
80.8% (13.3/80.8/1.13; sec/%/INR) of that of control; par-
tial thromboplastin time was 27.1 sec (normal, 26.5-41). The
plasma level of Protein C and S activity were in the normal
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Cerebral Infarction in IgG Multiple Myeloma with Hyperviscosity
Cerebral infarction is an uncommon complication in multiple myeloma with hyper-
viscosity. Serum hyperviscosity may cause a variety of clinical manifestations includ-
ing bleeding from mucosal membranes, congestive heart failure, retinopathy, and
various neurologic deficits. These manifestations have been attributed to the pres-
ence of large quantities of asymmetrical molecules of high molecular weight in the
serum. We recently experienced a case of multiple myeloma with acute cerebral
infarction, which caused by hyperviscosity, as an initial manifestation in IgG multi-
ple myeloma, and reviewed the relevant literature of myeloma presenting with the
stroke. A 68-yr-old woman abruptly developed hypesthesia and monoplegia in the
left leg. The stroke confirmed by the brain MRI and MR angiography, which revealed
acute infarction at the right anterior cerebral artery territory. On admission, routine
blood tests showed a slight decrease in hemoglobin and a marked increase in ery-
throcyte sedimentation rate. Peripheral blood smear, serum protein electrophore-
sis, serum visocity, and bone marrow aspiration showed that she had IgG multiple
myeloma with hyperviscosity. She was treated by chemotherapy with cyclophos-
phamide and discharged with the improved clinical condition.
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range. Serum creatinine was 0.6 mg/dL (normal, 0.6-1.5),
serum sodium 137 mEq/L (normal, 135-153), potassium
4.1 mEq/L (normal, 3-5), total calcium 7.1 mg/dL (normal,
8.6-10.6), ionized calcium 2.4 mEq/L (normal, 2.0-2.4), and
uric acid 1.5 mg/dL (normal, 2.4-7). The total serum protein
concentration was 9.6 g/dL (normal, 6.0-8.0), albumin was
1.8 g/dL (normal, 3.5-5.5), and globulins were 7.8 g/dL.
Serum protein electrophoresis (SPEP) revealed hyperpro-
teinemia, hypoalbuminemia and a prominent spike at the
gamma-globulin region (Fig. 2). Levels of immuno-globunins
were as follows: IgG 6,060 mg/dL (normal, 700-1,600), IgA
23.1 mg/dL (normal, 70-400), IgM 55.4 mg/dL (normal,
40-230), IgE 17.8 mg/dL (normal, 0.0-100) and  2-micro-
globulin 1.08 mg/L (normal, 0.7-3.4). Her relative serum
viscosity at 37℃was 5.2 (normal, 1.4 to 1.8). Random urine
protein was 23 mg/dL (normal, 1.0-14.0), but Bence-Jones
protein was negative in urine. 
Osteolytic areas in several bones were detected. Roentgeno-
grams revealed multiple lytic lesions of the skull and right
6th rib, and compression fracture of 9th thoracic vertebrae
body. Bone marrow examination confirmed the diagnosis of
myeloma. 
She was treated by chemotherapy (Cyclophosphamide 200
mg/m2 per day) with steroid pulse and then prednisone (70
mg/day) for 5 days, where and she remained on intermittent
chemotherapy. Every four weeks, routine blood tests and levels
of immunoglobulins were performed. At 3 months, her lab-
oratory data were within normal limits. There was no recur-
rence of hyperviscosity syndrome or stroke during the follow-
up of 25 months.
DISCUSSION
The typical features of multiple myeloma include bone
pain, weakness, fatigue, fever and infection. Neurologic symp-
toms occur in a minority of patients with multiple myeloma:
Hypercalcemia may produce lethargy, weakness, depression,
and confusion; bony damage and collapse may lead to spinal
cord compression, radicular pain, and loss of bowel and blad-
der control; a bulky cranial multiple myeloma invading cere-
brum may result in quadriparesis and headache (4); infiltra-
tion of peripheral nerves by amyloid can be a cause of carpal
tunnel syndrome and other sensorimotor mono- and poly-
neuropathies; hyperviscosity may lead to headache, fatigue,
visual disturbances, retinopathy, dementia (5, 6), and cere-
bral infarction (7, 8). However, one bears in mind that mul-
tiple myeloma may be present with a neurological disease.
Hyperviscosity is defined on the basis of the relative vis-
cosity of serum as compared with water. Whereas normal
Fig. 1. T2-weighted (A) and diffusion-weighted (B) axial MRI scans show acute cerebral infarction on the callosomarginal territory of right
anterior cerebral artery. MR angiography (C) has no stenosis on intracranial arteries.
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Fig. 2. Serum protein electrophoresis (SPEP) shows a sharp peak
in the gamma globulin region. Relative fraction of gamma globu-
lin region on SPEP was 42.6% of the total (9.3 g/dL).
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relative serum viscosity is 1.8, symptoms of hyerviscosity
occur at a level of 5 to 6, a level usually reached at parapro-
tein concentrations of approximately 40 g/L for IgM, 50 g/L
for IgG3, and 70 g/L for IgA (9). Hyperviscosity occurs rel-
atively infrequently in patients with multiple myeloma, but
one study reported an incidence of 4.2% among patients with
IgG protein (10). The hyperviscosity syndrome is an uncom-
mon complication in IgG multiple myeloma. Its occurrence
has been ascribed to the presence in the serum of high molec-
ular weight polymers of the IgG proteins. In our case, the
serum viscosity was 5.2, and the serum IgG 6,060 mg/dL.
Major neurologic deficits occur in more than 25% of patients
with myeloma and hyperviscosity syndrome (10-12). Lethar-
gy, hemiparesis, seizures, coma, and acute confusional states
are most frequently cited. Minor complaints include dizziness,
vertigo, headache, and impaired learning. Meanwhile, hyper-
viscosity caused by multiple myeloma might also have con-
tributed to the stroke.
We reported a 68-yr-old patient who developed monople-
gia of the left leg as the first manifestation of multiple myelo-
ma with hyperviscosity. This case was rare in that it involved
plasma cell leukemia with cerebral infarction associated with
serum hyperviscosity. We searched for cases of multiple myelo-
ma with hyperviscosity presenting with cerebral infarction,
and found only 2 reports (13, 14). Clinical conditions in which
this possible role of hyperviscosity in cerebral infarction could
be demonstrated have not been reported so far. In another
reported cases of cerebral infarction in multiple myeloma,
the serum hyperviscosity was not studied. Our case had no
significant atherosclerotic lesion on intra- and extracranial
vessels, and no risk factors of stroke except old age. There-
fore, we suggest that hyperviscosity plays a key role in the
pathogenesis of stroke in her with multiple myeloma, our
case then, is consistent with the hypothesis that chronic blood
hyperviscosity antedates the onset of symptomatic cerebrovas-
cular disease.
Thus, in patients with multiple myeloma, the monitor-
ing of plasma viscosity was of major importance in order to
evaluate the risk of cerebral infarction and decide the man-
agement for the prevention of stroke.
We believe that our patient represents a rare case of IgG
multiple myeloma associated with blood hyperviscosity and
cerebral infarction. Based on our case study, and a review of
the literature, we suggest that markedly elevated level of
serum globulin in a patient with cerebral infarction requires
measurement of blood viscosity, especially in patients with
multiple myeloma.
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